A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F09%3A00202043" target="_blank" >RIV/00216208:11140/09:00202043 - isvavai.cz</a>
Alternative codes found
RIV/00179906:_____/09:00201864 RIV/00669806:_____/09:00202552
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer
Original language description
In this study- clinical phase II the efficacy and safety of the fully oral combination of oral vinorelbine (Navelbine oral) plus capacitabine (Xeloda) in metastatic breast cancer (MBC) patients pretreated with antracycline, was evaluated.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FJ - Surgery including transplantology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2009
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Anticancer Research
ISSN
0250-7005
e-ISSN
—
Volume of the periodical
29
Issue of the periodical within the volume
2
Country of publishing house
GR - GREECE
Number of pages
4
Pages from-to
—
UT code for WoS article
000263731300031
EID of the result in the Scopus database
—